Who is sponsoring NCT03801330?

NCT03801330 is sponsored by Blue Marble Rehab Inc.

What drugs are being tested in NCT03801330?

Interventions in NCT03801330: Usual Care Pulmonary Rehabilitation Program, Pulmonary Rehabilitation Software-Based Home Program.

Is NCT03801330 still recruiting?

NCT03801330 is currently completed. Last updated 9 June 2023.

Last reviewed 2023-06-09 · How we verify

NCT03801330

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inspiration Point-A Digital Pulmonary Rehabilitation Tool Management Interventions

Completed NA Last updated 9 June 2023

What this trial tests

NA trial testing Usual Care Pulmonary Rehabilitation Program in COPD in 48 participants. Completed in 25 April 2023.

Timeline

1 November 2020

Primary endpoint
25 April 2023

25 April 2023

Quick facts

Lead sponsor	Blue Marble Rehab Inc
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	48
Start date	1 November 2020
Primary completion	25 April 2023
Estimated completion	25 April 2023
Sites	4 locations across United States

Drugs / interventions tested

Usual Care Pulmonary Rehabilitation Program
Pulmonary Rehabilitation Software-Based Home Program

Conditions studied

COPD — all drugs for COPD →

Sponsor

Blue Marble Rehab Inc

Who can join

18 and older, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to measure the feasibility of use of a digital pulmonary rehabilitation tool compared with standard care home program pulmonary rehabilitation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility, Usability, and Pilot Efficacy Study of a Software-Enabled, Virtual Pulmonary Rehabilitation with Remote Therapeutic Monitoring.
Flynn S, Mosher CL, Cornelison S, Rao E, et al · · 2025 · cited 2× · PMID 39906676 · DOI 10.2147/copd.s484558

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other Blue Marble Rehab Inc trials

Trials by the same sponsor.

NCT06619496 — Health in Motion Pragmatic Clinical Trial - WRAPAROUND · NA · completed
NCT05016141 — Health in Motion- A Pragmatic Clinical Trial- Home · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03801330 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Blue Marble Rehab Inc
Last refreshed: 9 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03801330.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing